...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Sept. 12, 2018

I wonder if there is any particular reason they moved the AGM to Sept from Dec.

tada

Share
New Message
Please login to post a reply